ZEVRA THERAPEUTICS, INC. Cash Flow Statement
ZVRA|1 years of annual SEC 10-K data (FY2015-FY2015)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid. All figures from audited SEC 10-K filings.
ZEVRA THERAPEUTICS, INC. used $4M in operating cash flow and negative free cash flow of $4M in FY2015.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.20 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2015 |
|---|---|
| Net Income | -$5.2M |
| Depreciation & Amortization | $68.0K |
| Operating Cash Flow | -$4.3M |
| Capital Expenditures | $51.0K |
| Free Cash Flow | -$4.4M |